Tissue response to composite hydrogels for vertical bone augmentation in the rat.

Area of Science:

• Biomaterials Science
• Surgical Innovation
• Preclinical Research

Background:

• Bone augmentation is crucial for treating bone defects.
• Developing reliable preclinical models is essential for testing bone regenerative therapies.
• Hydrogel composites offer potential for controlled delivery of growth factors like bone morphogenetic protein-2 (BMP-2).

Purpose of the Study:

• To establish a robust preclinical animal model for evaluating bone augmentation.
• To assess the efficacy of oligo(poly(ethylene glycol) fumarate) (OPF) and gelatin hydrogel composites releasing BMP-2 for bone augmentation.
• To compare different BMP-2 release profiles in a novel rat calvarial model.

Main Methods:

• A novel rat calvarial model was developed with rigid immobilization of bilateral implants.
• Hydrogel composites of OPF and gelatin microparticles loaded with varying BMP-2 release profiles were implanted.
• Control groups included material without BMP-2 and empty cassettes.

Main Results:

• The developed animal model met the design criteria for rigid immobilization and avoidance of sutures.
• No significant difference in bone augmentation was observed between hydrogel composite groups and controls after 4 weeks.
• Increased osteoclastic bone resorption was noted in BMP-2 releasing groups, though the cause remains unclear.

Conclusions:

• A viable preclinical rat model for bone augmentation studies was successfully established.
• The tested hydrogel composites, despite BMP-2 release, did not achieve significant bone augmentation in this model.
• Further refinement of hydrogel composite formulations is recommended to enhance their bone regenerative potential.